Ovid Therapeutics Appoints Harvard Professor Dr. Anna Greka to Board of Directors

Ovid Therapeutics announced on Wednesday the appointment of Dr. Anna Greka to its board of directors. Dr. Greka, a physician-scientist and biotech innovator, joins the company’s leadership team to provide oversight and guidance as the firm continues its work in the biopharmaceutical sector.

Dr. Greka currently serves as a professor at Harvard Medical School and holds a faculty position at Brigham and Women’s Hospital, where she leads the Greka Lab. Her professional background includes extensive research in kidney disease and the development of novel therapeutic approaches. She also serves as the director of the Kidney Disease Initiative at the Broad Institute of MIT and Harvard. In her new role at Ovid Therapeutics, Dr. Greka will participate in board-level decision-making processes alongside existing directors.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

Author

GOAI